4.17
price up icon5.30%   0.21
pre-market  プレマーケット:  3.76   -0.41   -9.83%
loading
前日終値:
$3.96
開ける:
$3.98
24時間の取引高:
89,322
Relative Volume:
1.04
時価総額:
$151.71M
収益:
-
当期純損益:
$-19.90M
株価収益率:
-7.8679
EPS:
-0.53
ネットキャッシュフロー:
$-19.80M
1週間 パフォーマンス:
+17.80%
1か月 パフォーマンス:
-15.76%
6か月 パフォーマンス:
-3.81%
1年 パフォーマンス:
+70.20%
1日の値動き範囲:
Value
$3.98
$4.195
1週間の範囲:
Value
$3.335
$4.195
52週間の値動き範囲:
Value
$2.14
$6.8184

Diamedica Therapeutics Inc Stock (DMAC) Company Profile

Name
名前
Diamedica Therapeutics Inc
Name
セクター
Healthcare (1148)
Name
電話
(763) 496-5454
Name
住所
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Name
職員
28
Name
Twitter
@diamedica
Name
次回の収益日
2025-03-17
Name
最新のSEC提出書
Name
DMAC's Discussions on Twitter

DMAC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DMAC
Diamedica Therapeutics Inc
4.17 151.71M 0 -19.90M -19.80M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.47 125.74B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
599.76 61.57B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
600.51 36.40B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
242.61 30.36B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
256.16 24.89B 3.81B -644.79M -669.77M -6.24

Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-07 開始されました H.C. Wainwright Buy
2024-04-24 再開されました Craig Hallum Buy
2023-06-22 アップグレード Oppenheimer Perform → Outperform
2021-04-09 開始されました Oppenheimer Outperform
2021-02-17 開始されました ROTH Capital Buy
2020-10-30 開始されました Guggenheim Buy
2020-07-08 開始されました Maxim Group Buy
2019-04-30 開始されました Dougherty & Company Buy
2019-03-05 開始されました Lake Street Buy
すべてを表示

Diamedica Therapeutics Inc (DMAC) 最新ニュース

pulisher
Apr 22, 2025

LPL Financial LLC Buys 11,500 Shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

Apr 22, 2025
pulisher
Apr 20, 2025

Financial Contrast: BioVie (NASDAQ:BIVI) vs. DiaMedica Therapeutics (NASDAQ:DMAC) - Defense World

Apr 20, 2025
pulisher
Apr 15, 2025

DiaMedica Therapeutics: Stroke Developer With Low Cash Reserve (NASDAQ:DMAC) - Seeking Alpha

Apr 15, 2025
pulisher
Apr 13, 2025

Raymond James Financial Inc. Purchases Shares of 15,267 DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

Apr 13, 2025
pulisher
Mar 27, 2025

(DMAC) Trading Report - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 22, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Price Target Raised to $10.00 - Defense World

Mar 22, 2025
pulisher
Mar 22, 2025

Equities Analysts Offer Predictions for DMAC Q1 Earnings - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

DiaMedica Therapeutics Reports 2024 Financial Results - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

DiaMedica Therapeutics Announces Closing of $8.5 Million Public Offering of Common Shares - Business Wire

Mar 21, 2025
pulisher
Mar 19, 2025

H.C. Wainwright lifts DiaMedica stock target to $10 on trial hopes - Investing.com Canada

Mar 19, 2025
pulisher
Mar 19, 2025

H.C. Wainwright lifts DiaMedica stock target to $10 on trial hopes By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 19, 2025
pulisher
Mar 19, 2025

DiaMedica Therapeutics Inc (DMAC) Q4 2024 Earnings Call Highlights: Strong Financial Position ... - Yahoo

Mar 19, 2025
pulisher
Mar 18, 2025

DiaMedica Therapeutics’ Optimistic Earnings Call Highlights - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Earnings call transcript: DiaMedica Q4 2024 results and stock surge By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Earnings call transcript: DiaMedica Q4 2024 results and stock surge - Investing.com India

Mar 18, 2025
pulisher
Mar 17, 2025

DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results - BioSpace

Mar 17, 2025
pulisher
Mar 17, 2025

DiaMedica Therapeutics Reports 2024 Financial Results and Strategic Advancements - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

DiaMedica Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

DIAMEDICA THERAPEUTICS Earnings Results: $DMAC Reports Quarterly Earnings - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Insider Stock Buying Reaches US$9.00m On DiaMedica Therapeutics - Yahoo Finance

Mar 17, 2025
pulisher
Mar 17, 2025

Where are the Opportunities in (DMAC) - Stock Traders Daily

Mar 17, 2025
pulisher
Mar 15, 2025

DIAMEDICA THERAPEUTICS Earnings Preview: Recent $DMAC Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025
pulisher
Mar 11, 2025

DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025 - Business Wire

Mar 11, 2025
pulisher
Mar 11, 2025

DiaMedica Therapeutics (DMAC) to Release Quarterly Earnings on Tuesday - Defense World

Mar 11, 2025
pulisher
Mar 08, 2025

Insiders At DiaMedica Therapeutics See Good Returns After Buying Stock Worth US$9.00m - Simply Wall St

Mar 08, 2025
pulisher
Mar 07, 2025

DiaMedica Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 06, 2025

DiaMedica announces board member Richard Pilnik’s retirement - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

DiaMedica announces board member Richard Pilnik’s retirement By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Trading (DMAC) With Integrated Risk Controls - Stock Traders Daily

Mar 06, 2025
pulisher
Mar 06, 2025

Y Intercept Hong Kong Ltd Takes $81,000 Position in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

Mar 06, 2025
pulisher
Feb 25, 2025

DiaMedica Therapeutics Appoints Daniel J. O’Connor to Board - MSN

Feb 25, 2025
pulisher
Feb 24, 2025

DiaMedica welcomes new board member with biopharma leadershi By Investing.com - Investing.com Nigeria

Feb 24, 2025
pulisher
Feb 24, 2025

DiaMedica welcomes new board member with biopharma leadershi - Investing.com

Feb 24, 2025
pulisher
Feb 24, 2025

DiaMedica Therapeutics Appoints Daniel J. O’Connor to the Board of Directors - Business Wire

Feb 24, 2025
pulisher
Feb 21, 2025

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Short Interest Down 8.4% in January - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

DiaMedica reports on DM199 stroke treatment mechanism By Investing.com - Investing.com Nigeria

Feb 20, 2025
pulisher
Feb 20, 2025

DiaMedica reports on DM199 stroke treatment mechanism - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

DiaMedica Therapeutics Announces Publication Of Dm199'S Mechanism Of Action For The Treatment Of Acute Ischemic Stroke In The Journal Stroke - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

DiaMedica Therapeutics Announces Publication of DM199’s Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke - Business Wire

Feb 20, 2025
pulisher
Feb 13, 2025

Learn to Evaluate (DMAC) using the Charts - Stock Traders Daily

Feb 13, 2025
pulisher
Feb 10, 2025

DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire

Feb 10, 2025
pulisher
Feb 10, 2025

DiaMedica's Game-Changing Stroke Treatment Takes Center Stage at Major Healthcare Conference (DMAC) - Stock Titan

Feb 10, 2025
pulisher
Feb 05, 2025

Short Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Grows By 14.5% - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Trading Down 1.5%Here's Why - MarketBeat

Feb 04, 2025

Diamedica Therapeutics Inc (DMAC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Diamedica Therapeutics Inc (DMAC) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Giuffre Randall Michael
Director
Feb 13 '25
Option Exercise
2.56
17,000
43,570
392,412
Von Koch Thomas
10% Owner
Jun 28 '24
Buy
2.50
1,200,000
3,000,000
5,526,435
STAHLBERG JAN
10% Owner
Jun 28 '24
Buy
2.50
1,200,000
3,000,000
5,221,608
$20.54
price up icon 2.04%
$68.96
price down icon 2.60%
$32.03
price up icon 1.07%
$36.70
price up icon 10.44%
$120.54
price up icon 4.97%
biotechnology ONC
$256.16
price up icon 2.82%
大文字化:     |  ボリューム (24 時間):